Items Tagged ‘Stages II-III Bladder Cancer’

March 30th, 2015

Votrient® plus Taxol® Promising in Relapsed and Refractory Bladder Cancer

By

The treatment combination of Votrient® (pazopanib) plus Taxol® (paclitaxel) appears active against bladder cancer that has not responded to or come back after previous therapy. These findings were presented at the 2015 Genitourinary Cancers Symposium on February 26–28 in Orlando, Florida. Bladder cancer is diagnosed in roughly 50,000 men and 17,000 women annually in the […]

View full entry

Tags: Bladder Cancer, News, paclitaxel, pazopanib, Phase II study, Recurrent Bladder Cancer, Stages II-III Bladder Cancer, Taxol, Votrient


July 29th, 2014

Studies Evaluate Robot Assisted Cystectomy Treatment of Bladder Cancer

By

The bladder is a hollow organ located in the pelvis. Its primary function is to store urine. The bladder has a muscular wall that allows it to get larger and smaller as urine is stored or emptied. Bladder cancer is diagnosed in roughly 50,000 men and 17,000 women annually in the United States.  Patients with […]

View full entry

Tags: Bladder Cancer, cystecomy, News, rarc, robotic-assisted radical cystectomy, Stages 0-I Bladder Cancer, Stages II-III Bladder Cancer


June 23rd, 2014

Survival Benefit with Immediate Adjuvant Chemotherapy in Invasive Bladder Cancer

By

Results from a recent Phase III clinical trial suggest that patients with invasive bladder cancer may benefit from treatment with immediate adjuvant chemotherapy. These finding were presented at the 2014 American Society of Clinical Oncology (ASCO) meeting held in Chicago, May 31–June 3. Patients with Stage III, or invasive, bladder cancer have cancer that invades […]

View full entry

Tags: Bladder Cancer, News, Recurrent Bladder Cancer, Stage III Bladder Cancer, Stage IV/Metastatic Bladder Cancer, Stages II-III Bladder Cancer, surgery


June 17th, 2014

Immediate Cisplatin-Based Chemotherapy Extends Progression-Free Survival in Invasive Bladder Cancer

By

A report at the 2014 American Society of Clinical Oncologists meeting indicates that immediate use of cisplatin-based chemotherapy offers significant improvement in progression-free survival over deferred treatment in invasive bladder cancer patients. The study concerned only patients who have had prior surgical resection. There was no significant improvement measured in overall survival. The EORTC clinical […]

View full entry

Tags: asco, Bladder Cancer, cisplatin, invasive bladder cancer, News, Stage III Bladder Cancer, Stages II-III Bladder Cancer


January 24th, 2013

Robotic Bladder Cancer Surgery Safe and Effective

By

Robotic-assisted surgery for invasive bladder cancer is effective and results in less bleeding and shorter hospital stays when compared to the traditional open procedure, according to the results of a study published in the Journal of Urology. The bladder is a hollow organ located in the pelvis. Its primary function is to store urine. The bladder […]

View full entry

Tags: Bladder Cancer, News, Recurrent Bladder Cancer, Stage III Bladder Cancer, Stage IV/Metastatic Bladder Cancer, Stages 0-I Bladder Cancer, Stages II-III Bladder Cancer


April 30th, 2012

Adding Chemotherapy to Radiation Reduces Bladder Cancer Recurrence

By

Chemotherapy plus radiation reduces the risk of recurrence in muscle-invasive bladder cancer patients by nearly 50% compared to radiation alone, according to the results of a study published in the New England Journal of Medicine.[1] Bladder cancer is diagnosed in roughly 50,000 men and 17,000 women annually in the United States. Patients with T2-T4a bladder cancer […]

View full entry

Tags: Bladder Cancer, News, Stage IV/Metastatic Bladder Cancer, Stages II-III Bladder Cancer, Urology


August 24th, 2011

Study Explores New Approach to Boosting the Immune System after Cancer Treatment

By

Researchers are seeking participants for a Phase II clinical trial that will explore whether an investigational treatment can help the immune system recover after cancer treatment. Cancer treatments such as chemotherapy and radiation therapy often deplete the immune system. Recovery takes time, particularly for older patients, and may not be complete. This can worsen the […]

View full entry

Tags: Adjuvant (I-III, A-C) Colon Cancer, Bladder Cancer, Breast Cancer, Colon Cancer, News, Stage I Node Negative Breast Cancer, Stage III Bladder Cancer, Stages II-III Bladder Cancer, Stages II-III Breast Cancer


June 14th, 2011

Liposomal Cisplatin Safe for Patients with Renal Insufficiency

By

Liposomal cisplatin (Nanoplatin®), a chemotherapy drug still in clinical trials, does not cause damage to the kidneys and appears to provide at least equal anti-cancer effects as cisplatin (Platinol®) among cancer patients with renal insufficiency.  These results were recently presented at the 2011 annual meeting of the American Society of Clinical Oncology. Cisplatin (Platinol®) is […]

View full entry

Tags: Bladder Cancer, Lung Cancer - Non-Small Cell, News, Stage IV/Metastatic Bladder Cancer, Stages I-IIIA Lung Cancer - Non-Small Cell, Stages II-III Bladder Cancer, Stages IIIB-IV Lung Cancer - Non-Small Cell


March 18th, 2010

Combined Modality Therapy Preserves Bladder and Offers Long-term Survival in Invasive Bladder Cancer

By

Combined modality therapy (CMT) preserves the bladder, achieves complete response (CR), and offers long-term survival in approximately 70% of patients with invasive bladder cancer, according to the results of a 15-year study presented at 2010 American Society of Clinical Oncology Genitourinary Symposium March 5-7 in San Francisco.[1] The bladder is a hollow organ located in […]

View full entry

Tags: Bladder Cancer, News, Stages II-III Bladder Cancer